Way To Whack A Mole? FDA Warning Letters To Seek Recurrent “Bad Actors”
Executive Summary
FDA plans to provide more specific guidance to industry on what constitutes deceptive advertising, Commissioner Mark McClellan said
You may also be interested in...
J&J Retin-A Micro TV Ad Cited By FDA; Clear Skin Not Matched By Clear Audio
FDA is advising J&J to make its risk presentation clearer - and the skin of its models less clear - in future advertising for Retin-A Micro
DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task
FDA's Office of the Chief Counsel has assigned two additional lawyers to review draft regulatory letters from the Division of Drug Marketing, Advertising & Communications
FDA Chief Counsel, Ad Division Concur On 94% Of Violation Letters, Troy Says
FDA's Office of the Chief Counsel concurs with 94% of the Division of Drug Marketing, Advertising & Communications' enforcement letters, Chief Counsel Daniel Troy said